Related Experiment Video

Updated: Aug 23, 2026

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
04:30

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat

Published on: February 4, 2021

Hyperlipidaemia and aortic valve disease

Anne Bjørhovde Rossebø1, Terje R Pedersen

  • 1Cardiology Department, Aker University Hospital, Oslo, Norway. anne_rossebo@hotmail.com

Current Opinion in Lipidology
|July 10, 2004
PubMed

Insights

Degenerative aortic valve stenosis shares risk factors with atherosclerosis, including hyperlipidaemia. Further research is needed to confirm if lipid-lowering interventions can effectively treat this condition.

Area of Science:

  • Cardiovascular Medicine
  • Geriatrics
  • Pathology

Background:

  • Degenerative aortic valve stenosis is a prevalent condition in the elderly population.
  • Traditional atherosclerotic risk factors, such as hyperlipidaemia, have been implicated in its development.
  • Understanding these risk factors is crucial for developing effective interventions.

Purpose of the Study:

  • To review the role of various risk factors in degenerative aortic valve stenosis.
  • To explore the potential for therapeutic interventions targeting these risk factors.
  • To elucidate the relationship between lipid abnormalities and aortic stenosis.

Main Methods:

  • Literature review of studies investigating risk factors for degenerative aortic valve stenosis.
  • Analysis of associations between lipid profiles, inflammatory markers, and aortic stenosis.
  • Examination of animal models with cholesterol-rich diets to understand disease mechanisms.

Main Results:

  • Lipid abnormalities (e.g., high lipoprotein(a), apolipoprotein E4 allele) are associated with aortic stenosis.
  • Inflammatory markers are present in both plasma and excised aortic valves.
  • Animal studies show similarities between cholesterol-induced lesions and early-stage aortic stenosis.

Conclusions:

  • Degenerative aortic valve stenosis shares etiological factors with atherosclerosis, including hyperlipidaemia and inflammation.
  • The findings suggest that aortic stenosis may be amenable to interventions targeting lipid metabolism.
  • Randomized controlled trials are necessary to validate the efficacy of lipid-modifying therapies in patients with aortic valve stenosis.
Abstract

More Related Videos

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

Related Concept Videos

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...